Site updated at Wednesday, 22 June 2016

Living with Dementia


Sanofi to test Parkinson’s drug with Michael J. Fox Foundation

French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson’s disease.

Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi’s AVE8112, a drug that has shown promise… Sanofi to test Parkinson’s drug with Michael J. Fox Foundation   

Living with Dementia

dementia patients care1 - dementia care program1 - memory tests1 - cardiac surgery2 - agitation2 - parkinsons disease10 - schizophrenic1 - neuroanatomical changes1 - bucknill1 - reducing anxiety1 - pdd3 - emotional lability1 - benzodiazepine1 - penn medicine1 - memory restoration1 - guv membrane1 - cortical atrophy1 - peripheral arterial disease1 - thiamine deficiency4 - dementia resistant1 - alzheimer's association6 - alzheimer’s disease8 - korsakoff's syndrome10 - mmse1 - phosphorylated tau1 - dementia135 - mild alzheimer's disease1 - hip fracture1 - apraxia3 - sahlgrenska academy1 -